1. Effect of silencing Bcl-2 expression by small interfering RNA on radiosensitivity of gastric cancer BGC823 cells
   Hong-Tao Liu et al, 2013, Asian Pacific Journal of Tropical Medicine CrossRef
2. Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells
   Yuting Gu et al, 2017, Oncology Letters CrossRef
3. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma
   JIANG WANG et al, 2015, Molecular Medicine Reports CrossRef
4. Enhancer of Zeste Homology 2 (Ezh2), an Epigenetic Regulator: A Possibility for Prostate Cancer Treatment
   Sanjay Kumar et al, 2016, Epigenetic Advancements in Cancer CrossRef
5. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis
   Xu Wang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
6. EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair
   Allyson E. Koyen et al, 2020, Oncogene CrossRef
7. The pharmacological and biological importance of EZH2 signaling in lung cancer
   Maliheh Entezari et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression
   Dovilė Kavaliauskaitė et al, 2017, BioMed Research International CrossRef
9. Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition
   Nishanth Gabriel et al, 2022, Cancer Research CrossRef
10. Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
    Daphné Morel et al, 2020, Nature Reviews Clinical Oncology CrossRef
11. Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells
    Hyo Won Chang et al, 2024, Cellular Signalling CrossRef
12. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Xiangjiao Meng et al, 2014, Radiation Oncology CrossRef
13. EZH2 Silencing with RNA Interference Induces G2/M Arrest in Human Lung Cancer CellsIn Vitro
    Hui Xia et al, 2014, BioMed Research International CrossRef
14. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
    Bisrat G Debeb et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
15. RNAi Therapeutic Platforms for Lung Diseases
    Yu Fujita et al, 2013, Pharmaceuticals CrossRef
16. Exosome miR-101–3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2
    Hongwen Sun et al, 2024, Pathology - Research and Practice CrossRef
17. Non-coding RNAs in lung cancer
    Biagio Ricciuti et al, 2014, Oncoscience CrossRef
18. Resolving DNA Damage: Epigenetic Regulation of DNA Repair
    Panagiotis Karakaidos et al, 2020, Molecules CrossRef
19. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
    Anthos Christofides et al, 2016, Oncotarget CrossRef
20. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
    Xiaoning Wu et al, 2019, The Prostate CrossRef